Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ hu?Q,[+o
-^ )
0c
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© gN2$;hb?
uvNLm]*
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© xvP=i/SO
i!H)@4jX
1.Co-stimulators (or co-stimulating molecules) 4o+SSS
"4Joou"U
2.NK-kB ]} D^?g^
2nNBX2o&_
3.Immunoglobulin superfamily ^!Y]l
4?+K:e #F
4.antigen-presenting cell (APC) Rm@#GP`
] !7%)
5.death domain 9CBKU4JQ
3.i$lp`t
6.CCR and CXCR QO1pwrX<
|PGF g0li
7.Lectin (or mitogen) u|;?FQ$M
xwuGJ
8.Clusters of differentiation, CD) o,-p
[1b
&a;{ed1B
9.B7 family #$5"&SM
PK C}!>2
10.Cytotoxic T lymphocyte, CTL) Hw0S/ytY
4*AkUkP:T
11.IL-15 and IL-15 receptor (IL-15R) a&^HvXO(>(
'E\/H17
12.MHC restriction CP]nk0
/)%$xi
13.Affinity-chromatography v3p0
}3825
14.Cyctosprin A, CsA `EXo =Dqc
3_DwqZ 'O
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) Ci-CY/]s
u=6LPwiI
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© GhJ<L3
`4SwdW n
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 Ad}Nc"O
La2f]+sV
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ \ u*R6z
#+"1">l
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ C8Oh]JF4d
Y9}ga4
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© .A Dik}o
<eh<4_<qF
ÃâÒßѧרҵ£º ;RW0Dn)Q
T5_/*`F
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ a5k![sw\
1CR)1H
Ïû»¯ÄÚ¿Æ£º O>@
ChQF
vNDf1B5z
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ |e_'%d&
;%Zu[G`C
ѪҺ²¡Ñ§×¨Òµ£º 'PvOOhm,
~]Weyb[N
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿